deaths (OS)

endometrial cancer endometrial cancer

versus Standard of Care (SoC)
lenvatinib in association vs. Standard of Care (SoC) 1 certainty unassessable-32%

endometrial cancer - (neo)adjuvant (NA) endometrial cancer - (neo)adjuvant (NA)